Technology News and Research

RSS
New optogenetic technology could turn on immune cells to attack melanoma tumors

New optogenetic technology could turn on immune cells to attack melanoma tumors

Small peptide TAxI holds promise for carrying biologic drugs into spinal cord

Small peptide TAxI holds promise for carrying biologic drugs into spinal cord

New study could help explain critical shortcomings in stem cell-driven therapies for heart disease

New study could help explain critical shortcomings in stem cell-driven therapies for heart disease

Researchers discover factor that controls embryonic stem cell development

Researchers discover factor that controls embryonic stem cell development

Atlas io system allows infectious diseases to be detected in less than 30 minutes

Atlas io system allows infectious diseases to be detected in less than 30 minutes

Long-term survival of 'blue babies' and patients with congenital heart defects reasonably good

Long-term survival of 'blue babies' and patients with congenital heart defects reasonably good

Asterias Biotherapeutics simplifies capital structure through previously announced Asset Swap with BioTime

Asterias Biotherapeutics simplifies capital structure through previously announced Asset Swap with BioTime

Special issue of FMCH focuses on care and disease management interventions in China, Australia

Special issue of FMCH focuses on care and disease management interventions in China, Australia

Innovative tool helps observe protein aggregates linked to neurodegenerative diseases

Innovative tool helps observe protein aggregates linked to neurodegenerative diseases

Clear Guide SCENERGY CT-Ultrasound fusion system receives FDA 510(k) clearance

Clear Guide SCENERGY CT-Ultrasound fusion system receives FDA 510(k) clearance

Diagnostic imaging equipment market in Saudi Arabia expected to grow at CAGR of 7.9% during 2015-2020

Diagnostic imaging equipment market in Saudi Arabia expected to grow at CAGR of 7.9% during 2015-2020

IRIDEX's Cyclo G6 laser system receives CE Mark approval for treatment of glaucoma

IRIDEX's Cyclo G6 laser system receives CE Mark approval for treatment of glaucoma

Johns Hopkins engineers successfully use mind-controlled prosthetic arm to control movements of fingers

Johns Hopkins engineers successfully use mind-controlled prosthetic arm to control movements of fingers

Electronic health records could help identify people who have undiagnosed type 2 diabetes

Electronic health records could help identify people who have undiagnosed type 2 diabetes

First two patients treated in multi-center clinical trial for perivascular renal denervation

First two patients treated in multi-center clinical trial for perivascular renal denervation

Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

IoT Tech Expo Europe 2016: It's time for large corporates to engage with SMEs, says EveryWare

IoT Tech Expo Europe 2016: It's time for large corporates to engage with SMEs, says EveryWare

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

Proof-of-concept data for NanoString's Hyb & Seq chemistry presented at AGBT Meeting

Proof-of-concept data for NanoString's Hyb & Seq chemistry presented at AGBT Meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.